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Summary 
An immature v-abl-transformed mast cell line (V3-MC) 
was derived from a mouss that developed systemic 
mastocytosis after transplantation of v-abl-infected 
bone marrow cells. V3-MCs injected intravenously into 
adult BALB/c mice infiltrated the liver, spleen, and in- 
testine by day 6 and underwent progressive dlfferenti- 
ation and maturation, eventually resembling indige- 
nous mast cells. In terms of their protease content, 
the V3-MCs that localized in the liver and spleen dif- 
fered from those in the intestine, and both differed 
from the cultured V34Cs. The acquired expression of 
certain proteases and the loss of expression of other 
proteases in these tissue V3-MCs defines particular 
phenotypes and indicates that the differentiation and 
maturation of mast cell-committed progenitor cells 
are primarily regulated by factors in the different tissue 
microenvironments. 
Introduction 
Mast cells consist of a heterogeneous family of immune 
effector cells that exhibit subclass-specific functional re- 
sponses. Despite the involvement of mast cells in various 
biologic processes, information about how their differenti- 
ation and maturation are regulated is just beginning to 
emerge. Mast cells are derived primarily from multipoten- 
tial stem cells in the bone marrow (Kitamura et al., 1976; 
Nakahata et al., 1982; Schrader et al., 1981; Sonoda et 
al., 1982; lhle et al., 1983; Yunget al., 1983; Nakanoet al., 
1985; Jarboe et al., 1989; Leftwich et al., 1992). However, 
unlike other hematopoietic cell types, mature mast ceils 
are not found in the peripheral blood. Thus, it has been 
BDrs. Gurish and Pear contributed equally to this study. 
proposed that mast cells complete their development only 
when they migrate into specific tissues. 
One scheme to classify mast cells is based on the com- 
position of their granules. Neutral proteases account for the 
vast majority of granule protein in mast cells and, over the 
last few years, eight different mouse mast cell proteases 
have been identified, cloned, or both (reviewed by Hunt 
and Stevens, 1995). The pattern of expression of the neu- 
tral proteases varies among the mast cells found in differ- 
ent tissues. For example, in the BALB/c mouse, the mast 
cells that populate the skin express mouse mast cell prote- 
ase(mMCP)4, mMCP-5, mMCP-8, mMCP-7, and carboxy- 
peptidaseA(mMC-CPA)(Stevensetal., 1994). Incontrast, 
the mast cells that populate the intestine of the helminth- 
infected BALBlc mouse preferentially express mMCP-1 
(Le Trong et al., 1989) and mMCP-2 (Serafin et al., 1990). 
To account for the heterogeneity observed in tissue mast 
cells, either distinct populations of mast cell-committed 
progenitors must exist in the bone marrow that are each 
programmed to express a specific panel of proteins or 
the final stages of mast cell differentiation and maturation 
must be controlled by the tissue microenvironment. 
One approach to understand the factors that regulate 
the development of mast cells in vivo has been to study 
the effects of different cytokines on cultured mast cells. 
Immature nontransformed bone marrow-derived mast 
cells (mBMMCs) have been obtained by culturing bone 
marrow cells from BALB/c mice for 2-3 weeks in medium 
containing interleukin-3 (IL-3) (Ihle et al., 1983). The pro- 
teoglycan content and/or neutral granule protease content 
of these mBMMCs can be modulated by subsequent co- 
culture with fibroblasts (LeviSchaffer et al., 1988) or cul- 
ture in medium containing various combinations of 11-3, 
IL-4, IL-g, IL-lo, and c-kit ligand (Tsai et al., 1991; Gurish 
et al., 1992a; Ghildyal et al., 1992a, 1993; Eklund et al., 
1993). However, these in vitro systems have the disadvan- 
tage that many of the mast cells obtained possess granule 
phenotypes that are different from known populations of 
tissue mast cells. An alternative approach to study mast 
cell differentiation and maturation has been to immortalize 
mast cell progenitors by transformation with retroviral on- 
cogenes. Immortalized mast cell lines have been obtained 
by in vitro infection of hematopoietic cells with Abelson 
murine leukemia virus (Pierce et al., 1985) Harvey sar- 
coma virus (Rein et al., 1985) or Kirsten sarcoma virus 
(Reynolds et al., 1988). Although these cell lines have 
proved important for the identification of mast cell-specific 
proteins and genes, their continuous release of infectious 
retrovirus complicates their usefulness for the study of 
tissue-directed pleiotropism in vivo. 
Techniques permitting helper-free retrovirus production 
offer a potential solution to the problem that hindered the 
in vivo use of immortalized mast cell lines. Using these 
techniques, we have generated mast cell lines (designated 
V3-MC and V7-MC) from BALB/c mice that developed sys- 
temic mastocytosis after lethal irradiation and transplanta- 
tion with bone marrow infected by high titer helper-free 
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Figure 1. Histochemical and lmmunohistochemical Analysis of the Spleen from a Primary Mastocytosis Mouse 
Sections of a spleen from an irradiated BALB/c mouse reconstituted with web/-transduced bone marrow cells were evaluated histochemically with 
methyleneblue(a)orimmunohistochemicallywithanti-mMCP-2immunoglobulin(b),anti-mMCP-5immunoglobulin(c), anti-mMCP-6immunoglobulin 
(d), anti-mMCP-7 immunoglobulin (e), or anti-mMC-CPA immunoglobulin (9. The findings were similar in the other three primary mastocytosis mice 
that were analyzed. 
v-abl-expressing retrovirus. These mast cell lines are simi- 
lar to IL+dependent BALBlc mBMMC in terms of their 
granularity and protease phenotype, and the intravenous 
injection of one of these cell lines into BALB/c mice results 
in a systemic mastocytosis. Examination of the mast cell 
phenotypes in several tissues shows that the injected V3- 
MCs acquire the neutral protease phenotype of the indige- 
nous mast cells of a particular tissue. This finding supports 
a model in which the tissue microenvironment controls the 
final stages of mast cell development. 
Results 
Development of Mastocytosis in Lethally Irradiated 
Syngeneic Mice after the Adoptive Transfer of 
pGDVYW-Transduced Bone Marrow Cells 
To evaluate the transforming capacity of a high titer helper- 
free v&/-expressing retrovirus, 10 lethally irradiated 
BALB/c mice were injected intravenously with bone mar- 
row that had been infected in vitro by PGD”-‘~‘. As as- 
sessed by polymerase chain reaction (PCS) analysis, 3 
weeks after the injection of pGDv”bf-transduced bone 
marrow cells, all mice contained cells with proviral DNA 
in their blood (data not shown). These mice showed evi- 
dence of cachexia, decreased activity, and decreased 
grooming 4-7 weeks after adoptive transfer. The white 
blood cell counts of 9 of the mice were similar to those of 
control animals, but one mouse had a markedly elevated 
white blood cell count due to leukemic blasts. The mice 
were sacrificed when they showed evidence of disease, 
and all had hepatosplenomegaly and lymphadenopathy. 
Histologic analysis revealed that the liver, spleen (Figure 
l), lymph nodes, and bone marrow were populated by 
large numbers of granulated mast cells. In addition to mas- 
tocytosis, 5 of the mice had foci composed of immature 
blasts in the liver, spleen, lymph nodes, and bone marrow. 
The histochemistry and immunohistochemistry of the 
spleen of one of the original mastocytosis mice is illus- 
trated in Figure 1. Based on the metachromasia obtained 
after staining with methylene blue or toluidine blue, the 
spleen of this mastocytosis mouse contained >I 00 mast 
cells/mm2. The infiltrating mast cells were 12-20 urn in 
diameter, possessed a slightly eccentric nucleus typical 
of a normal mast cell, and appeared throughout the con- 
nective tissue trabeculae and in the sinusoids of the red 
pulp. Some of the proliferating mast cells were intermixed 
with lymphocytes in the white pulp but, in general, the 
germinal centers were spared. As assessed immunohisto- 
chemically, most, if not all, of the mast cells in the spleen 
of this mastocytosis mouse expressed mMCP-2, mMCP-5, 
mMCP-6, mMCP-7, and mMC-CPA (Figure 1). When non- 
fractionated bone marrow cells from this primary masto- 
cytosis mouse were injected into 4 sublethally irradiated 
mice, all recipient animals became moribund within 4 
weeks. The recipient mice developed a systemic masto- 
cytosis similar to that of the original animals, indicating 
that the disease was readily transferable. 
Derivation of Mast Cell and Lymphoblastoid Cell 
Lines from the Primary Mastocytosls Mice 
The Vl, V6, and V9 lymphoblastoid cell lines were derived 
by culturing bone marrow cells from the primary animals 
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Figure 2. Characterization of the V3MC and V7-MC Lines 
(A) A blot containing Xbal- or Hindllldigested genomic DNA (5 kg/lane) from SAL& mouse liver (lane 1) and from the V3-MCs (lane 2). V7-MCs 
(lane 3), and V6 lymphoblastoid cells (lane 4) was analyzed with the 3’ abl cDNA probe described in Experimental Procedures to assess proviral 
integration. Xbal cleaves once in each retroviral long terminal repeat, resulting in an -7 kb pGD “+Qpecific fragment if the entire pmvirus is 
integrated into the genome of the cell line. The arrow on the left indicates the - 7 kb DNA fragment that is not in liver but is in all three cell lines. 
Hindlll cleaves once in the pGDW retroviral vector. Thus, the number of provirus integrations in each cell line was determined by blot analysis 
of isolated genomic DNA digested with Hindlll. The arrow and bracket on the right indicate the specific POD-derived fragment in each cell line. 
The Hindlll results were confirmed using EcoRl which also cleaves pGD@” once (data not shown). The 9.4, 6.6, and 6.0 kb DNA fragments that 
are present in all four lanes are derived from the endogenous C-E&/ gene. Size markers, in kilobases, are indicated on the left. 
(6) Cytospinsof cultured V3-MCs were evaluated histochemically with methylene blue (a) or immunohistochemically with anti-mMCP-2 immunoglobu- 
lin (b), anti-mMCP-5 immunoglobulin (c), anti-mMCP-6 immunoglobulin (d), anti-mMCP-7 immunoglobulin (e), anti-mMC-CPA immunoglobulin (f), 
antic-kit immunoglobulin (g), or anti&/ immunoglobulin (h). 
(C) Slots containing total RNA from SALBlc mSMMCs (lane l), V3MCs (lane 2). and V7-MCs (lane 3) were analyzed with gene-specific probes 
for mMCP-1, mMCP-2. mMCP-4. mMCP-5, mMCP-6, mMCP-7. mMC-CPA, FcsRla, c-kit, abl. and actin. 
that had mastocytosis and concomitant lymphoma. These arate mice and were the only mast cell lines generated 
three lymphoblastoid cell lines grew rapidly, and lines be- from the original 10 diseased animals. Unlike the lym- 
gan to be established 2 weeks after initiation of the cul- phoblastoid cell lines, the mast cell lines did not rapidly 
tures. The V34C and V7-MC lines were derived from sep- proliferate until the fifth week of culture. Because the lym- 
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phoblastoid and mast cell lines were derived from separate 
mice, it could not be determined whether or not the two 
cell types were derived from a common v&l-immortalized 
multipotential progenitor cell. 
DNA blot analysis revealed that the V3MC and V-/-MC 
lines, as well as the V8 lymphoblastoid cell line, each con- 
tained a single integrated copy of the pGDvd provirus 
in their genomes at distinct sites (Figure 2A). As assessed 
by SDS-PAGElimmunoblot analysis, the V&MC and V7- 
MC lines both expressed high levels of the 180 kDa v&l 
protein (data not shown). V3-MCs and W-MCs possess 
thin cytoplasmic projections (microvilli, microplicae, or 
both), a moderate amount of cytoplasm, and a single ec- 
centric generally spherical or slightly indented nucleus 
(Figure 28). As assessed histochemically, both cell lines 
are poorly granulated in vitro. They also contain low 
amounts of histamine (<lOO ng/106 cells). As assessed 
immunohistochemically, cultured V3-MCs contain detect- 
able levelsof abl, c-kit, mMC-CPA, mMCP-5, and mMCP-8 
proteins, but not mMCP-2 or mMCP-7 proteins(Figure 28). 
The cultured V3-MCs stain less intensely with anti-mMCP-8 
immunoglobulin than with anti-mMCP-5 immunoglobulin, 
and individual cells within the cultures differ in their inten- 
sity of staining by anti-mMCP-5 immunoglobulin. Never- 
theless, when >300 cells in a culture were analyzed immu- 
nohistochemically, almost every cell contained some 
mMCP-5 and mMCP-8. 
RNA blot analysis indicated that V3-MCs and V7-MCs 
contain high steady-state levels of the transcripts that en- 
code c-kit, FceRla, mMC-CPA, and mMCP-5, but not 
mMCP-1, mMCP-2, mMCP-4, or mMCP-7 (Figure 2C). V3- 
MCs and V7-MCs also contain high steady-state levels of 
an - 8 kb transcript that was corecognized by abl (Figure 
2C), gag, and neo cDNAs. This prominent transcript in the 
immortalized mast cell lines is therefore derived from the 
introduced ‘provirus. The mMCP-8 gene-specific probe 
used in the RNA blot analysis hybridizes to a transcript 
in both cell lines that is less abundant than the mMCP-5 
transcript. Its size is also 100-300 bp larger than the 
mMCP-8 transcript in BALB/c mBMMCs (Figure 2C). Ex- 
cept for the lack of the mMCP-7 transcript, the V3-MC and 
V7-MC lines phenotypically resemble mBMMCs derived 
by culturing BALB/c bone marrow cells for 3 weeks in 
IL-3-containing medium (Figure 2C). Because the steady- 
state level of the mMCP-7 transcript in mBMMCs de- 
creases substantially with continued culture of these cells 
in medium containing IL-3 (McNeil et al., 1992b), the low 
steady-state level of the mMCP-7 transcript in the V3-MC 
and V7-MC lines is probably a consequence of their pro- 
longed cultivation. 
Adoptive Transfer with HI&chemical and 
lmmunohistochemlcal Chamcterlzation of 
Specific Tissues In the V3 Mastocytosls Mouse 
Because the VSMC line is indistinguishable from the V7- 
MC line in terms of its morphology, histochemistry, and 
protease phenotype, the VSMC line was arbitrarily chosen 
for subsequent adoptive transfer experiments. In prelimi- 
nary experiments, it was found that a reproducible sys- 
temic mastocytosis develops in normal nonirradiated syn- 
geneic recipients after intravenous injection of V3-MC. 
Following adoptive transfer of V3-MCs into naive 4- to 
8-week-old BALB/c mice, different tissues from replicate 
animals were evaluated over an interval of -4 weeks for 
changes in their granule maturity and protease phenotype. 
With time, all V3 mastocytosis mice exhibited lethargy, 
dyspnea, a distended abdomen, and, eventually, death. 
Their spleens increased - 15-fold in weight and had a 
mottled appearance with tan infiltrates. The spleens con- 
tained - 200 mast cells/mm2 2 weeks after adoptive trans- 
fer of V3-MCs, and numerous granulated V3-MCs were 
observed in mitosis in the spleen and liver. The livers in- 
creased - lO-fold in weight during the same period, and 
eventually had multiple punctate pale tan areas. In addi- 
tion to the splenic and hepatic involvement, small nodules, 
often macroscopic, studded the mesentery and serosal 
surfaces of the intestine and the pleural surfaces of the 
lung. Lymph nodes were enlarged and tan. Despite the 
aggressive mastocytosis that developed in the liver, 
spleen, lung, stomach, and intestine of V3-MC-treated 
BALBlc mice, increased numbers of mast cells were not 
detected in the ear skin of the diseased animals. 
Because V3-MCs first populated the liver, kinetic histo- 
chemical studies were focused on this organ. Individual 
mononuclear cells with clear agranular cytoplasm ap 
peared in the hepatic sinusoids 3 days after the injection 
of V3-MCs and in the epithelium among the hepatocytes 
(Figure 3). By 1 week, the V3-MCs in the liver were more 
numerous and they had small blue granules when stained 
by methylene blue or hematoxylin, azure II, and eosin-Y 
(HAE). At day 10, colonies of V3-MCs several millimeters 
in diameter were detected that often infiltrated and dis- 
placed the cords of hepatocytes (Figure 3). The V3-MCs 
in these colonies possessed metachromatic granules. Im- 
Figure 3. HAE Staining of V3-MCs in the Livers of Mastocytosis Mice 
VSMCs were adoptively transferred into nonirradiated BALBlc mice and the animals were analyzed 3, 10, 13, and 25 days later. Sections of liver 
were stained with HAE to evaluate the number of mast cells in this tissue, as well as the extent of their granule maturation. The arrow in the day 
3 specimen indicates a nongranulated cell that has infiltrated the liver. Since subsequent studies revealed that this agranular cell type expresses 
abl protein, the cell most likely is a VI-MC. The two arrows in the day 25 specimen indicate histochemically mature mast cells. The brackets in 
the panels correspond to 10 pm. 
Figure 4. lmmunohistochemistry of the Livers of V3 Mastocytosis Mice 
The livers in the depicted analyses were removed 2-3 weeks after V3-MCs were adoptively transferred into nonirradiated BALB/c mice. Sections 
were prepared and evaluated immunohistochemically with anti-c-kit immunoglobulin (a), anti-mMCP-2 immunoglobulin (b), anti-mMCP-5 immuno- 
globulin (c), anti-mMCP-5 immunoglobulin (d), anti-mMCP-7 immunoglobulin (e), or anti-mMC-CPA immunoglobulin (9. (b) and (d) are at low 
magnification. 
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mature agranular cells were still present in the sinusoids 
and liver cords at day 13, but most of the V3-MCs had 
developed large eosin-Y+ granules. At days 10-16, when 
the mast cells exhibited substantial histochemical matura- 
tion, numerous eosinophils were also present among the 
mast cell infiltrates in the liver (data not shown). By day 
25 (Figure 3), many of the V3-MCs in the liver had dense 
granules that were stained better by azure II. These mast 
cells histochemically resembled the mature indigenous 
mast cells in the spleen. Accompanying the massive infil- 
trate of mast cells in the liver of the day 25 mastocytosis 
mouse were areas infiltrated by polymorphonuclear leuko- 
cytes and macrophages, and bordered by fibroblasts. 
However, there was a marked decrease in the number of 
eosinophils associated with this late stage of the disease. 
While undergoing histocheniical maturation, the gran- 
ules of the V3-MCs in the liver expressed increasing 
amounts of mast cell proteases, some of which were not 
detected in the cultured cells. As assessed by immunohis- 
tochemistry, the V3-MCs that populated the liver at day 
3 expressed mMCP-5, mMCP-6, mMC-CPA, c-kit, and abl 
protein, but not mMCP-2 or mMCP-7 protein (data not 
shown). By week 2, the V3-MCs in the liver contained even 
more mMCP-5, mMCP-6, and mMC-CPA protein and now 
also contained mMCP-2 and mMCP-7 protein (Figure 4). 
There was no apparent diminution in the level of these 
proteases in the liver-localized V3-MCs during the late 
stages of the mastocytosis (days 26-35). 
The V3-MCs that populated the spleen and small intes- 
tine also underwent a differentiation process. In the 
spleen, the adoptively transferred V3-MCs filled the red 
pulp and connective tissue trabeculae, impinging on the 
white pulp, and they eventually infiltrated the germinal 
centers of the lymphoid follicles. These splenic V3-MCs 
underwent developmental and maturational changes simi- 
lar to the changes exhibited by V3-MCs in the liver, ex- 
pressing mMCP-2, mMCP-5, mMCP-6, mMCP-7, and mMC 
CPA in their granules. For comparison, mast cells in the 
normal BALB/c mouse spleen are rare (9-13 mast cells/ 
5.2 mm* transverse section, n = 6); but, as assessed im- 
munohistochemically (n = 3), virtually all of the mast cells 
in the normal spleen expressed mMCP-5, mMCP-6, 
mMCP-7, and mMC-CPA protein. Approximately 20% of 
the mast cells in the spleen of the normal BALB/c mouse 
also expressed mMCP-2 protein. 
In the small intestine, mast cells accumulated predomi- 
nantly in the lamina propria of the mucosa. There were 
also small numbers of mast cells within the smooth muscle 
layers and on the serosal surfaces of this organ. Cells that 
morphologically resembled V3-MCs and reacted with the 
anti&/ immunoglobulin were detected in the lamina pro- 
pria 6 days after adoptive transfer (Figure 5). These cells 
lacked metachromatic granules and did not react with anti- 
mMCP-2 immunoglobulin or anti-mMCP-5 immunoglobu- 
lin. Nevertheless, 2-3 weeks after adoptive transfer, the 
V3-MCs in the lamina propria and between the epithelial 
cells in the mucosa of the small intestine possessed 
metachromatic granules (Figure 6). Thus, as in the liver 
and spleen, the V3-MCs that populated the intestine un- 
derwent granule maturation. Unlike in the liver (see Figure 
4) or spleen, the V3-MCs in the intestine at week 2 pre- 
ferentially contained mMCP-2 protein with little, if any, 
mMCP-5, mMCP-6, mMCP-7, or mMC-CPA protein (Fig- 
ure 6). In contrast, the V3-MCs and the indigenous mast 
cells in the smooth muscle and on the serosal surface of 
the intestine expressed predominantly mMCP-5 (Figure 
6), mMCP-7, and mMC-CPA, rather than mMCP-2. 
RNA Blot Analysis of Tissues of the V3 
Mastocytosis Mouse 
As assessed by RNA blot analysis, no mast cell protease 
or abl transcript was detected in abundance in the liver, 
spleen, or small intestine of the normal BALB/c mouse 
(data not shown). However, 2-3 weeks after adoptive 
transfer of V3-MCs, the liver (Figure 7) and spleen (data 
not shown) of the V3 mastocytosis mouse contained high 
steady-state levels of the - 6 kb v-abl transcript and every 
mast cell protease transcript that has so far been cloned. 
In contrast, the only abundantly expressed transcripts in 
the intestine of the 2-3 week V3 mastocytosis mouse were 
those that encode v-abl, mMCP-1, and mMCP-2 (Figure 
7). Similar findings wereobtained when four of the granule 
proteases were assessed in three independent subcloned 
lines of V3-MC (designated K&MC-I, KSMC-II, and V3- 
MC-III). After adoptive transfer into separate mice, these 
subcloned V3-MCs populated and proliferated in the liver 
and intestine. In the liver, they expressed high steady-state 
levels of the mMCP-1, mMCP-2, mMCP-4, and mMCP-5 
transcripts at day 17 (data not shown). However, in the 
intestine, they expressed high steady-state levels of the 
mMCP-1 and mMCP-2 transcripts but not the mMCP-4 
and mMCP-5 transcripts at day 17 (data not shown). The 
RNA blot and immunohistochemical data are summarized 
in Table 1. 
Figure 5. Histochemical and lmmunohistochemical Analysis of the Small Intestines of V3 Mastocytosis Mice 6 Days after Exposure to VSMCs 
Serial sections (a and d; b and 8; c and 9 of the small intestinal mucosa 6 days after adoptive transfer of V3-MCs were evaluated histochemically 
with HAE (d) or immunohistochemically with anti-ablimmunoglobulin (a, b, and c), anti-mMCP-2 immunoglobulin (e), or anti-mMCP-5 immunoglobulin 
(9. The arrows indicate cells expressing abl protein (a, b, and c) whose granules do not stain with HAE (d). These ebl-positive cells also are not 
recognized by anti-mMCP-2 immunoglobulin (e) or anti-mMCP-5 immunoglobulin (9. 
Figure 6. Histochemical and lmmunohistochemical Analysis of the Small Intestines of V3 Mastocylosis Mice 2 Weeks After Exposure to V3-MCs 
Sections of intestine were prepared and evaluated histochemically with HAE (a) or immunohistochemically with anti-mMCP-2 immunoglobulin (b), 
anti-mMCP-5 immunoglobulin (c), anti-mMCP-6 immunoglobulin (d), anti-mMCP-7 immunoglobulin (e), or anti-mMCCPA immunoglobulin (9. The 
submucosa of the depicted V3 mastocytosis mouse contains very few mast cells. However, the insert in the bottom right of (c) is a mast cell in 
the submucosa of the same section that is stained by anti-mMCP-5 immunoglobulin. 
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Figure 7. RNA Blot Analysis of Mast Cell Protease Transcripts in the 
Livers and Small Intestines of V3 Mastocytosis Mice 
Blots containing total RNA from cultured V6-MCs, and from the intes- 
tine and liver of a V3 mastocytosis mouse 2 weeks after adoptive 
transfer were analyzed with gene-specific probes for mMCP-1, mMCP- 
2, mMCP-4, mMCP-5, mMCP-6, mMCP-7, mMC-CPA, and abl. 
Discussion 
The lineage-restricted mast cell progenitor line, VB-MC, 
was derived from a mouse that had developed systemic 
mastocytosis after transplantation of bone marrow cells 
transduced with v-abl (Figure 1). Several characteristics 
of V3-MCs make this cell line a unique reagent for studying 
mast cell differentiation in vivo. First, it does not release 
infectious v-abl virions. As a result, all developmentally 
regulated changes are due to changes in the injected cell 
line itself, rather than infection of new targets after intrave- 
nous injection. Second, by virtue of its single integrated 
provirus, the V3MC line appears to have been derived 
from a single clone. In further support of its clonal deriva- 
tion, the protease expression pattern of the V9MC line 
has not varied during the year that it has been cultured. 
Third, V3-MCs share many phenotypic characteristics with 
immature mast cell precursors and can be induced to dif- 
ferentiate in vivo. 
Although adoptive transfer experiments in mast cell- 
deficient mice have shown that mast cell precursors are 
present in the peripheral blood (Sonoda et al., 1982) this 
population has not been purified. The best characterized 
immature mast cell is the IL-3-dependent mBMMC, and 
it is this population with which V3-MCs share many phe- 
notypic characteristics. In both cell types, histamine con- 
tent is less than 0.5 pg/cell and the neutral proteases 
expressed are mMCP-5, mMCP-8, and mMC-CPA. In 
mBMMCs and V3MCs, the steady-state, levels of the 
mMCP-1, mMCP-2, and mMCP-4 transcripts are below 
detection. One difference between the protease expres- 
sion pattern of mBMMCs and V3-MCs is that mMCP-7 is 
expressed only transiently in the former (McNeil et al., 
1992b). As the levels of this transcript fall with prolonged 
culture, its absence in V3-MCs may reflect the extended 
period that this line has been maintained in vitro. 
When the V3-MC line is adoptively transferred into 
BALBlc mice, a reproducible aggressive mastocytosis de- 
velops in the liver, spleen, and small intestine. The skin 
appears to be spared even at week 4, thereby emphasizing 
the importance of tissuedependent homing of immature 
progenitor cells. The observation that adoptively trans- 
ferred V3-MCs populate the spleen but not the skin of the 
BALBlc mouse is similar to findings obtained when mast 
cell-deficient WA@ mice are reconstituted with mouse 
bone marrow cells from their normal littermates (Kitamura 
et al., 1978; Du et al., 1994). No significant increase in 
the number of cutaneous mast cells was observed in the 
reconstituted WA%” mouse 5 weeks after adoptive transfer. 
Moreover, even 15 weeks after adoptive transfer, the den- 
sity of mast cells in the skin of the reconstituted W/l&” 
mouse does not approach that found in its normal lit- 
termate. Thus, mast cell repopulation of skin is a slow 
process in mast cell-deficient Wm mice. The VS-MC data 
suggest that this also is the case in mast cell-sufficient 
BALBlc mice. A number of factors could account for the 
failure of V3-MCs to populate the skin. Homing of commit- 
ted progenitors into the skin may preferentially occur at 
an earlier timepoint in ontogeny. V3-MCs may be too far 
along in their differentiation pathway or they may lack 
some critical adhesion factor. Alternatively, the skin may 
have a mechanism(s) that effectively regulates the number 
of mature and progenitor mast cells in the tissue. 
After transfer, abCexpressing agranulated cells are de- 
tectable in both the liver at day 3 and small intestine lamina 
propria at day 8. In the liver, these cells are found together 
with granulated V3-MCs, whereas in the small intestine 
lamina propria, the agranulated cells are present before 
any granulated cells are detected. Because cells that have 
no granules account for approximately 5% of the V3-MCs 
in vitro, it is possible that this population of agranulated 
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Table 1. Protease Expression of Cultured V3-MCs and Tissue-Localized VSMCs 
Culture& VSMC 
Liver W-MC Liverb VSMC 
(day 3) (week 2-3) 
Intestinal’ VIMC 
(day 6) 
IntestinaP V3MC 
Iweek 2-3) 
mMCP-1 ND 
mMCP-2 - 
mMCP-4 ND 
mMCP-5 + t- 
mMCP-6 +(weak) + 
mMCP-7 - - 
mMC-CPA + + 
* lmmunohistochemical data; ND, not determined. 
b lmmunohistochemical and RNA blot data. 
+ ND + 
+ - -I- 
-I- ND 
+ - 
+ - 
+ 
+ 
cells preferentially home to these tissues. Alternatively, 
the granulated V3MCs may degranulate or catabolize 
their granular proteases before or shortly after their ap 
pearance in these organs. 
With time, theV3MCs that proliferate in the liver(Figure 
3) spleen, and intestine (Figures 5 and 6) become increas- 
ingly metachromatic. This finding indicates either increased 
granule storage of serglycin proteoglycans or a change 
in the type of glycosaminoglycan synthesized onto the 
granule-localized proteoglycan peptide core. As assessed 
by RNA blot and immunohistochemical analyses, V3-MCs 
both differentiate and mature in tissues. V3-MCs that are 
present in the liver (Figures 4 and 7) and spleen of the 2- 
to 3-weekold mastocytosis mouse acquire expression of 
mMCP-1, mMCP-2, mMCP-4, and mMCP-7, while main- 
taining expression of the three granule proteases ex- 
pressed by the starting cultured cells (mMCP-5, mMCP-6 
and mMC-CPA) (Figure 2). This protease expression pat- 
tern is similar to that of a subpopulation of mast cells found 
in the spleen of normal BALB/c mice. The paucity of indige- 
nous mast cells in the normal liver has precluded their 
phenotyping. 
Numerous cytokines have been identified that influence 
protease expression in cultured mouse mast cells (Gurish 
et al., 1992a; Ghildyal et al., 1992a, 1992b, 1993). mBMMCs 
cultured first in the presence of IL-3 and then with the 
combination of IL-9 and c-kit ligand (Eklund et al., 1993) 
resemble the V3-MCs in the liver and spleen in expressing 
every known mast cell neutral protease. The present re- 
sults are a novel description of mast cells in vivo that ex- 
press all of the cloned mast cell proteases. It is possible 
that the protease phenotypes of the liver and spleen V3- 
MCs are induced by a similar combination of mast cell- 
regulatory cytokines. 
The V3-MCs in the small intestine lamina propria at week 
2-3 have developed a phenotype distinct from that found 
in liver and spleen at this time. The V3-MCs that initially 
populate the small intestine were not recognized by any 
of the mast cell protease-specific antibodies (Figure 5). 
However, by week 2-3, V3-MCs in the lamina propria ex- 
press principally mMCP-2 and little or no mMCP-5, mMCP- 
6, mMCP-7, or mMC-CPA (Figure 6). Since the steady- 
state levels of the mMCP-1 and mMCP-2 transcripts are 
comparably increased in the intestine of the mastocytosis 
mouse (Figure 7), it is presumed that the V3-MCs in the 
intestinal lamina propria also express mMCP-1 protein. 
Mast cells are rare inhabitants of the normal intestinal lam- 
ina propria and even rarer in the epithelium. Nevertheless, 
the mucosal mast cells that are found at both sites express 
mMCP-2 (Friend et al., 1995). Upon helminth infection, 
they become more abundant and continue to preferentially 
express mMCP-1 (Le Trong et al., 1969; Huntley et al., 
1999; Ghildyal et al., 1992b) and mMCP-2 (Serafin et al., 
1999; Ghildyal et al., 1992b; 1993). Therefore, the V3-MCs 
that reside in the small intestine mucosa not only are phe- 
notypically distinct from the V3-MCs in the liver and spleen 
but also take on the phenotypic characteristics of indige- 
nous mucosal mast cells. Although there were consider- 
ably fewer numbers of mast cells in the intestinal submu- 
cosa of the week 2 or 3 mastocytosis mouse compared 
with the numbers in the lamina propria, these cells express 
mMCP-5, mMCP-6, mMCP-7, and mMC-CPA but little or 
no mMCP-2. This granule protease phenotype is identical 
to the indigenous mast cells that reside in the submucosa. 
Thus, the dichotomy of phenotypes found in the mouse 
small intestine has been preserved in the phenotypes of 
the V3-MCs that populate these two regions of the in- 
testine. 
The studies of Kitamura and coworkers on the reconsti- 
tution of mice with bone marrow cells or with mBMMCs 
(Kitamuraet al., 1977,1976; Nakanoet al., 1965) indicated 
that mast cells differ from other hematopoieticderived 
cells in that they do not circulate in blood as mature cells. 
These studies also raised the possibility that mast cell 
heterogeneity was the result of the tissue-specific differen- 
tiation of a common progenitor. In Contrast, recent studies 
of human mast cell development (reviewed by lrani and 
Schwartz, 1994) led to the proposal that different popula- 
tions of mast cells arise from distinct progenitor cells. The 
current approach with the tissue-responsive V3-MCs pro- 
vides an opportunity to examine the pleiotropism of com- 
mitted mast cell progenitors in vivo in a mast cell-sufficient 
mouse. Our results argue against mast cell heterogeneity 
deriving from multiple progenitor populations. Instead, our 
data indicate that V3-MCs are capable of homing to sev- 
eral different tissues, where they undergo phenotypic 
changes, becoming indistinguishable from the indigenous 
mast cells. These changes involve both the acquisition 
and loss of specific granule-localized neutral proteases. 
In vitro studies have shown that different combinations of 
cytokines can modulate the protease expression patterns 
of cultured mBMMCs. Although the current studies do not 
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allow us to identify the mechanisms accounting for the 
tissue-specific mast cell phenotypes of the V3-MCs, it ap- 
pears that cytokines or other tissue-specific factors influ- 
ence the final steps of mast cell differentiation. 
Exfmrlmental Procedures 
Derlvatlon snd Use of a v&f-Transformed Mast Cell Llne 
to Create Systemic Maatocytosls In Mice 
The pGDW retroviral DNA construct used to transfecf Bose 23 cells 
has been previously described (Scott et al., 1991). as well as the cell 
transfection and cocultivation procedures (Pear et al., 1993). Parallel 
experiments showed that the v&l retroviral titer was - 2 x 10 focus- 
forming U/ml of retroviral supernatant. As assessed by the BAG cell 
assay (Pear et al., 1993, and references therein), replication-compe- 
tent virus was not present. The donor mice were 4- to 6-week-old male 
BALB/c mice (Jackson Laboratories) that had been pretreated with 
Sfluorouracil(lO0 mglg bodywt). The recipient mice (4 to 6-week-old 
BALB/c female mice that had received 900 cGy [two doses separated 
by 3 hr]) were injected intravenously with 0.5 to 1 .O x 1Q cells/mouse. 
Blood was isolated from the mice 3 weeks after marrow transplantation 
to determine white blood cell count indices and to prepare DNA for 
PCR analysis, as previously described (Daley and Baltimore, 1988; 
Daley et al., 1990). 
To derive growth factor-independent cell lines from the primary 
mastocytosis mice, bone marrow was obtained at the time of necropsy 
and cultured in enriched medium (Dulbecco’s modified Eagle’s me- 
dium supplemented with 100 U/ml penicillin, 100 pglml streptomycin, 
50 mM Pmercaptoethanol, and 20% fetal calf serum) for up to 3 
months. Two growth factor-independent mast cells lines (W-MC and 
VFW) and three growth factor-independent nonmast cell lines (VI, 
V8, and V9) were derived from different primary animals. As assessed 
by fluorescein-activated cell sorter analyses, the Vl , VB, and V9 cell 
lines were recognized by an antibody to 8220 but not by antibodies to 
Thyl.2, IgM, Gr-1 , or Mac-l (data not shown). Because these findings 
suggested that the Vl , VS, and V9 cell lines were of pre-B cell origin, 
they were not studied further. To ensure that the V3-MCs that populate 
the liver represent the same population of cells in the culture that 
populates the intestine, three independent subcloned W-MC lines 
(designated W-MC-I, W-MC-II, and V3-MC-III) were obtained by lim- 
iting dilution. 
V7-MCs and V3-MCs were maintained in vitro in enriched medium 
and were passaged twice each week. The histamine content of cul- 
tured V3-MCs was determined by radioimmunoassay (McBride et al., 
1988). For induction of systemic mastocytosis by adoptive transfer, 
l-4 x IW VSMCs in 0.2 ml of enriched medium were injected into 
the tail vein of nonirradiated syngeneic BALB/c mice. At various times 
after inoculation, the diseased mice were sacrificed and their tissues 
were processed immediately, as described below. 
Hlstochemlstry and Immunohlstochemlstry of V3-MCs and 
Various Tlsaues of the V3 Mastocytosls Mouse 
For immunoalkaline phosphatase staining (Boenisch et al., 1989). cul- 
tured V3-MCs cytocentrifuged (5 min; 28 x g) onto glass slides or 
isolated tissues from V3 mastocytosis mice were fixed for 4 hr at room 
temperature in 4% paraformaldehyde and 0.1 M sodium phosphate 
(pH 7.6) (Beckstead et al., 1981). Preparations were washed twice 
with phosphate-buffered saline (PBS) containing 2% dimethyl sulfox- 
ide, and then were suspended in 50 mM NH&l overnight at 4OC. 
Dehydration and embedding of the specimens were carried out in 
accordance with the JB-4 embedding kit instructions from Poly- 
sciences, Incorporated. After l-2 days of hardening, 1.5 pm thick 
sections of fixed and embedded tissue were cut on a ReichertAung 
Supracut microtome (Leica Corporation) using glass knives and picked 
up on glass slides. The slides were incubated sequentially for 15 min 
at 37°C in 2 mM CaC12 containing 0.25% trypsin, for 15 min at room 
temperature in PBS containing 0.05% Tween 20 and 0.1% bovine 
serum albumin, for 30 min at 37OC in PBS containing 0.05% Tween 
20 and 4% normal goat serum, and overnight at 4W in 4% normal 
goat serum containing affinity-purified rabbit anti-mast cell protease 
immunoglobulin, rat anti-mouse c-kit immunoglobulin (Pharmingen), 
or mouse anti&/ immunoglobulin (Schiff-Maker et al., 1986). Rabbit 
immunoglobulin (Ghildyal et al., 1993), anti-mMCP-5 im- 
munoglobulin (McNeil et al., 19923, anti-MCP6 immunoglobulin 
(N. G., unpublished data), anti-mMCP-7 immunoglobulin (Ghildyal et 
al., 1994), and anti-mMC-CPA immunoglobulin (Gurish et al., 1992b) 
were obtained against synthetic peptides that correspond to residues 
56-71, 146-162, 160-172, 160-172, and 146-157 in the respective 
protease. The anti& mouse monoclonal antibody (designated 24-21) 
used in this study reacts equally well with c&/and v-ab/(Schiff-Maker 
et al., 1986). The samples were washed, incubated for 40 min at room 
temperature in buffer containing biotin-labeled goat anti-rabbit IgG, 
goat anti-rat IgG. or goat anti-mouse IgG. Each was then washed twice 
inO.l% bovineserumalbumin and0.05% Tween20 in PBS, incubated 
for 40 min at room temperature in Vectastain ABC-AP reagent (Vector 
Laboratories), and then incubated for 15 min in the dark at room tem- 
perature in an alkaline phosphatase substrate solution. The cytochemi- 
cal data presented in Results were derived from 24 separate V3 masto- 
cytosis mice. Controls consisted of sections of tissue from four different 
mice treated with nonimmune IgG (Endogen, Incorporated) or without 
primary antibody. Cytospins of V3-MCs or tissue sections were coun- 
terstained with Gill’s hematoxylin in 20% ethylene glycol, and then 
coverslips with Immu-Mount (Shandon) were applied. 
For histological examination, cultured V3-MCs or serial 1.5 Cm 
thick glywlmethacrylate sections of various tissues from the normal 
BALB/c mouse or the V3 mastocytosis mouse were placed on wv- 
erslips or slides, air dried, and stained for 20 s in a 5% ethanolic 
solution of methylene blue (Matin et al., 1992). Alternatively, sections 
were incubated sequentially with double-strength hematoxylin for 2 
min, 1% aqueous eosin Y for 15 min. azure II for 1 min, and ethylene 
glywl monomethyl ether for 5 s (Beckstead et al., 1981). 
For quantitating the mast cells in a tissue, areas were traced from 
paraformaldehyde-fixed glycolmethacryiate-embedded blocks of tis- 
sue, sectioned at 1.5 pm thickness, and stained with methylene blue, 
toluidine blue, HAE, or with the immunoalkaline phosphatase proce 
dure. Using a drawing tube attachment to an optical Leitz microscope, 
the areas traced were then measured on a computer-controlled digitiz- 
ing board employing a Sigma Scan digitizing program (Jandel Scien- 
tific). Mast cells were counted on a Dialux 20 optical microscope with 
an oil immersion 50 x objective, and the results were expressed as 
the number of mast cells/mm2. The number of alkaline phosphatase 
immunoreactive mast cells was determined in a similar manner. Al- 
though qualitative differences were observed among the mast cells, 
the criteria for a VSMC being scored positive for the expression of a 
particular protease required at least three cytoplasmic granules 
stained with the protease-specific antibody. Data were expressed as 
the number of immunoreactive ceIWmm2. 
RNA Blot Analysls 
Tissues were surgically excised, immediately frozen in liquid nitro- 
gen, ground in liquid nitrogen with a mortar and pestle, and then ho- 
mogenized briefly in 4 M guanidinium thiocyanate. 0.5% sarcosyl, 
0.1 M P-mercaptoethanol, and 25 mM sodium citrate (Stevens et al., 
1994). Total RNA was isolated using the method of Chomczynski and 
Sacchi (1987) from the tissues of V3 mastocytosis mice, from cul- 
tured V3-MCs, and from control BALBlc mBMMCs (Razin et al., 
1984). The resulting RNA samples were denatured in formaldehyde/ 
formamide, electrophoresed in 1.3% formaldehyde-agarose gels, and 
transferred to MagnaGraph membranes (Micron Separations, lnwrpo 
rated) (Thomas, 1980). The blots were then incubated overnight at 
43OC in hybridization buffer containing 5x SSPE, 5x Denhardt’s 
buffer, 0.1% SDS, 100 pg/ml salmon sperm DNA, and a radiolabeled 
gene-specific probe for mMCP-1 (Le Trong et al., 1989; Huang et al., 
1991; Ghildyal et al., 1992b), mMCP-2 (Serafin et al., 1990), mMCP-4 
(Serafin et al., 1991; Ghildyal et al., 1992b), mMCP-5 (McNeil et al., 
1991). mMCP-6(Reynoldsetal., 1991). mMCP-7(McNeiletal.. 1992b). 
mMC-CPA (Reynolds et al., 1989), c-kit (Flanagan and Leder, 1990), 
or B-actin (Spiegelman et al., 1983). The RNA blots were washed at 
55°C-60°C in 15 mM NaCI, 1.5 mM sodium citrate, and 0.1% SDS 
and analyzed by autoradiography, by Betaswpe (Betagen), or by both. 
Blots were stripped and reanalyzed with other gene-specific probes. 
The abl probe used in this study corresponds to the 3’end of the gene. 
It was derived by PCR amplification of residues 3152 to 4582 of pGDd 
(Scott et al., 1991). The primers used for this PCR were 5’~TGGGGCA- 
AGGGACACAGAGT-3’ and 5XACAGGCAGTGAGGAGAGGT-3’. Be- 
s 
r 
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cause of their near identity, the obtained a6/ probe will recognize the 
-5.kb c-r&/ transcript and the - &kb pGDtiderived transcript 
equally well. However, the two related transcripts can be distinguished 
from one another by their diirent sizes in a RNA blot analysis. The 
geg probe used in this study was derived by PCR amplification of 
residues 700-1308 of pGDd (Scott et al., 1991). The primers used 
for this latter PCR were 5%GGTAGATGTCAAGAAGAGA-3’ and 5” 
TAAAGGTCAGAAGAGGAGA’. An - 9O&bp DNA probe (neo) was 
obtained from the neomycin-resistance gene by digesting pMClneo 
(Stratagene) with EcoRl and BamHI. The gag, ab/, and neo probes 
recognize the same transcript in pGD--immortalized ceils. 
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